Aureon Laboratories, Inc. Logo
Aureon Laboratories Named 2010 Recipient of Yonkers Hidden Treasure Award
May 05, 2010 08:00 ET | Aureon Laboratories, Inc.
YONKERS, N.Y., May 5, 2010 (GLOBE NEWSWIRE) -- Aureon Laboratories, Inc. announced today that the City of Yonkers named Aureon the 2010 recipient of the Yonkers Hidden Treasure Award. "On behalf of...
Aureon Laboratories, Inc. Logo
Aureon Laboratories Announces Name Change for Existing Post-Surgical Prostate Cancer Recurrence Test
March 05, 2010 08:00 ET | Aureon Laboratories, Inc.
YONKERS, N.Y., March 5, 2010 (GLOBE NEWSWIRE) -- Today, Aureon Laboratories, Inc. announced a new name for its post-prostatectomy, prognostic test available for patients who have undergone surgery to...
Aureon Laboratories, Inc. Logo
Aureon Laboratories Announces Appointment of New Executive Vice President and CFO
January 14, 2010 10:29 ET | Aureon Laboratories, Inc.
YONKERS, N.Y., Jan. 14, 2010 (GLOBE NEWSWIRE) -- Aureon Laboratories, Inc. today announced the appointment of Robert L. Van Nostrand as Executive Vice President and Chief Financial Officer. Mr. Van...
Aureon Laboratories, Inc. Logo
Aureon Laboratories Announces Hiring of Vice President of Sales
October 13, 2009 08:00 ET | Aureon Laboratories, Inc.
YONKERS, N.Y., Oct. 13, 2009 (GLOBE NEWSWIRE) -- Aureon Laboratories, Inc. today announced the hiring of David Brown as Vice President of Sales. Mr. Brown will provide leadership to the sales team and...
Aureon Laboratories, Inc. Logo
Aureon Laboratories Announces Appointment of New CEO
August 25, 2009 08:00 ET | Aureon Laboratories, Inc.
YONKERS, N.Y., Aug. 25, 2009 (GLOBE NEWSWIRE) -- Aureon Laboratories, Inc., a specialized laboratory dedicated to advancing personalized cancer treatment through predictive pathology, today announced...
Aureon Laboratories, Inc. Logo
Study Validates Aureon Technology to Predict Prostate Cancer Disease Progression From Biopsy Tissue
July 08, 2009 08:30 ET | Aureon Laboratories, Inc.
YONKERS, N.Y., July 8, 2009 (GLOBE NEWSWIRE) -- Aureon Laboratories, Inc., a specialized laboratory dedicated to advancing personalized cancer treatment through predictive pathology, today announced...